000 01444 a2200385 4500
005 20250516140736.0
264 0 _c20131024
008 201310s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.01761-12
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCorvec, Stéphane
245 0 0 _aTEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cMay 2013
300 _a2410-2 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmino Acid Substitution
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aBase Sequence
650 0 4 _aDrug Resistance, Multiple, Bacterial
_xgenetics
650 0 4 _aHumans
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aMolecular Sequence Data
650 0 4 _aProteus Infections
_xdrug therapy
650 0 4 _aProteus mirabilis
_xdrug effects
650 0 4 _abeta-Lactamases
_xgenetics
700 1 _aBeyrouthy, Racha
700 1 _aCrémet, Lise
700 1 _aAubin, Guillaume Ghislain
700 1 _aRobin, Frédéric
700 1 _aBonnet, Richard
700 1 _aReynaud, Alain
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 57
_gno. 5
_gp. 2410-2
856 4 0 _uhttps://doi.org/10.1128/AAC.01761-12
_zAvailable from publisher's website
999 _c22570791
_d22570791